588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Super Nk Cell Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	CC (42)
3x10 cart-38 cells Acute Myeloid Leukemia	University of Pennsylvania	P1	CC (41)
A-Car028 Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	P1	CC (41)
Allo-Revcar01-T Acute Myeloid Leukemia	AvenCell Therapeutics, Inc.	P1	CC (41)
Anti-Cd33 Car Nk Cells Acute Myeloid Leukemia	Xinqiao Hospital of Chongqing	P1	CC (41)
Anzurstobart Acute Myeloid Leukemia	Bristol-Myers Squibb	P1	CC (41)
bh-30236 Acute Myeloid Leukemia	BlossomHill Therapeutics	P1	CC (41)
cc-91633 Acute Myeloid Leukemia	Celgene	P1	CC (41)
cd33ko-hspc; cart33 Acute Myeloid Leukemia	University of Pennsylvania	P1	CC (41)
cd70-targeting car-t cells Acute Myeloid Leukemia	Baylor College of Medicine	P1	CC (41)
cll1 and cd38 dual-target car-t cell Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	CC (41)
cll1-cd33 ccar t cells Acute Myeloid Leukemia	iCell Gene Therapeutics	P1	CC (41)
Dc/Aml Fusion Cells Acute Myeloid Leukemia	Beth Israel Deaconess Medical Center	P1	CC (41)
Donor-Derived Cd123-Cd16 Bispecific Antibody-Modified Nk Cells Acute Myeloid Leukemia	Chunji Gao	P1	CC (41)
Eganelisib Acute Myeloid Leukemia	Jacqueline Garcia, MD	P1	CC (41)
gsk3745417 Acute Myeloid Leukemia	GlaxoSmithKline	P1	CC (41)
Hpc-A Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P2	CC (41)
Icp-248 Acute Myeloid Leukemia	Beijing InnoCare Pharma Tech Co., Ltd.	P1	CC (41)
Immunoglobulin G4, Anti-(Human Cd3 Antigen) (Recombinant Human Monoclonal Jnj-75348780 ?4-Chain), Disulfide With Recombinant Human Monoclonal Jnj-75348780 ? Chain, (229?126?),(232?129?)-Bis(Disulfide) With Immunoglobulin, Anti-(Human Sialic Acid-Binding Ig-Like Lectin 2) (Recombinant Human Single-Domain Vhh Fragment) Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Ipsc-Nk Cells Acute Myeloid Leukemia	Zhejiang University	P1	CC (41)
Jnj-54179060 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Jnj-64264681 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Jnj-64619178 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Jnj-70218902 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Jnj-80948543 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Jnj-87801493 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Jnj-89853413 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Jnj-90189892 Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Lapine T-Lymphocyte Immune Globulin Acute Myeloid Leukemia	Children's Oncology Group	P3	CC (41)
LY 3410738 Acute Myeloid Leukemia	Eli Lilly and Company	P1	CC (41)
Niclosamide Acute Myeloid Leukemia	Stanford University	P1	CC (41)
R-Tm123 Acute Myeloid Leukemia	AvenCell Therapeutics, Inc.	P1	CC (41)
Safimaltib Acute Myeloid Leukemia	Janssen Research & Development, LLC	P1	CC (41)
Siltuximab Acute Myeloid Leukemia	Nantes University Hospital	P1	CC (41)
Sti-6129 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	CC (41)
Sti-8591 Acute Myeloid Leukemia	Zhejiang ACEA Pharmaceutical Co. Ltd.	P1	CC (41)
Tbx-2400 Acute Myeloid Leukemia	Taiga Biotechnologies, Inc.	P1	CC (41)
tm123 Acute Myeloid Leukemia	AvenCell Therapeutics, Inc.	P1	CC (41)
TQB3455 Acute Myeloid Leukemia	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P1	CC (41)
ucd7 cart Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	CC (41)
Anti-Clever-1 Monoclonal Antibody Fp-1305 Acute Myeloid Leukemia	Faron Pharmaceuticals Ltd	P1/2	CC (40)
Anti-Flt3 Car-T Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P1/2	CC (40)
Astx029-01 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CC (40)
cll1/+cd33 car-t Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CC (40)
Ctx-712 Acute Myeloid Leukemia	Chordia Therapeutics, Inc.	P1/2	CC (40)
Cytokine-Treated Veto Cells Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CC (40)
Debio 1562M Acute Myeloid Leukemia	Debiopharm International SA	P1/2	CC (40)
Dordaviprone Acute Myeloid Leukemia	University of Nebraska	P1/2	CC (40)
Elranatamab Acute Myeloid Leukemia	CellCentric Ltd.	P1/2	CC (40)
Eras-007 Acute Myeloid Leukemia	Erasca, Inc.	P1/2	CC (40)

Showing 351 to 400 of 588 assets

PreviousPage 8 of 12Next